Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Cabozantinib. Cabozantinib is an oral tyrosine kinase inhibitor (TKI) used in the treatment of various cancers, including advanced renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), and medullary thyroid carcinoma (MTC). It works by inhibiting multiple kinases such as VEGFR, MET, RET, AXL, and KIT, which are involved in tumor growth, angiogenesis, metastasis, and drug resistance. By blocking these pathways, cabozantinib reduces tumor vascularization and proliferation. It is available in tablet and capsule forms, with specific formulations approved for different indications. Common side effects include diarrhea, fatigue, hypertension, hand-foot syndrome, decreased appetite, and weight loss. Serious risks include gastrointestinal perforation, hemorrhage, and thromboembolic events. Dose adjustments may be required for hepatic impairment or severe toxicities, and treatment should be closely monitored for adverse effects. Buy high quality Cabozantinib from Omsynth Lifesciences.
